Clinical outcomes and adverse events in patients hospitalised with COVID-19, treated with off-label hydroxychloroquine and azithromycin
Kelly et al., British Journal of Clinical Pharmacology, doi:10.1111/bcp.14482
https://c19hcq.org/kelly.html